Comparison of Digitally Delivered Gut-Directed Hypnotherapy Program With an Active Control for Irritable Bowel Syndrome
- 28 June 2024
- journal article
- research article
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 120 (2) , 440-448
Abstract
INTRODUCTION: Gut-directed hypnotherapy (GDH) treats irritable bowel syndrome (IBS), but its accessibility is limited. This problem may be overcome by digital delivery. The aim of this study was to perform a randomized control trial comparing the efficacy of a digitally delivered program with and without GDH in IBS. METHODS: Adults with IBS were randomized to a 42-session daily digital program with the GDH Program (Nerva) or without (Active Control). Questionnaires were completed to assess gastrointestinal symptoms through IBS Symptom Severity Scale (IBS-SSS), quality of life, and psychological symptoms (Depression Anxiety and Stress Scale-21) at regular intervals during the program and 6 months following the conclusion on the intervention. The primary end point was the proportion of participants with ≥50-point decrease in IBS-SSS between the interventions at the end of the program. RESULTS: Of 240/244 randomized participants, 121 received GDH Program—the median age 38 (range 20–65) years, 90% female, IBS-SSS 321 (interquartile range 273–367)—and 119 Active Control—36 (21–65), 91% female, IBS-SSS 303 (255–360). At program completion, 81% met the primary end point with GDH Program vs 63% Active Control ( P = 0.002). IBS-SSS was median 208 (interquartile range 154–265) with GDH and 244 (190–308) with control ( P = 0.004), 30% reduction in pain was reported by 71% compared with 35% ( P < 0.001), and IBS quality of life improved by 14 (6–25) compared with 7 (1–15), respectively ( P < 0.001). Psychological status improved similarly in both groups. DISCUSSION: A digitally delivered GDH Program provided to patients with IBS was superior to the active control, with greater improvement in both gastrointestinal symptoms and quality of life and provides an equitable alternative to face-to-face behavioral strategies.Keywords
Funding Information
- Mindset Health Pty Ltd
This publication has 31 references indexed in Scilit:
- A Randomized Parallel-group Study of Digital Gut-directed Hypnotherapy vs Muscle Relaxation for Irritable Bowel SyndromeClinical Gastroenterology and Hepatology, 2023
- Cognitive behavioural therapy for irritable bowel syndrome: 24-month follow-up of participants in the ACTIB randomised trialThe Lancet Gastroenterology & Hepatology, 2019
- Efficacy of individual and group hypnotherapy in irritable bowel syndrome (IMAGINE): a multicentre randomised controlled trialThe Lancet Gastroenterology & Hepatology, 2019
- Effect of Antidepressants and Psychological Therapies in Irritable Bowel Syndrome: An Updated Systematic Review and Meta-AnalysisAmerican Journal of Gastroenterology, 2019
- Long-Term Success of GUT-Directed Group Hypnosis for Patients With Refractory Irritable Bowel Syndrome: A Randomized Controlled TrialAmerican Journal of Gastroenterology, 2013
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- Dietary Triggers of Abdominal Symptoms in Patients With Irritable Bowel Syndrome: Randomized Placebo-Controlled EvidenceClinical Gastroenterology and Hepatology, 2008
- Cellular and humoral immunity, mood and exam stress: the influences of self-hypnosis and personality predictorsInternational Journal of Psychophysiology, 2001
- Quality of Life in Persons with Irritable Bowel Syndrome (Development and Validation of a New Measure)Digestive Diseases and Sciences, 1998
- Physiological effects of emotion: assessment via hypnosisThe Lancet, 1992